Altimmune Inc
Biotechnology
Healthcare
ALT
71.08 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
7.24
52 week high
9.85
high
7.73
52 week low
3.67
low
6.89
growth
-2.16 %
previous Close
7.19
P/E ratio
market cap
587 M
div yield
0
usd
Sep 2024
qoq
revenue
5.00 K
0.00 %
net incoming
-22.85 M
7.28 %
eps
0.00 %
8.17 %
eps surprise
8.17 %
net profit margin
-456900.00 %
359.00 %
operating incoming
-24.77 M
7.40 %
net change in cash
-25.65 M
-17.41 %
cash on hand
31.47 M
-44.91 %
cost of revenue
0.00 %
top top